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Abstract We have explored the potential of Trypanosoma
brucei as a eukaryotic expression system. Procyclic forms, which
correspond to an insect-adapted stage, can easily be cultured in
vitro. The cells grow to densities V10-fold greater than higher
eukaryotic cells and are not infectious for mammals. An
expression vector which can stably integrate into the genome
was used to express high levels of recombinant bovine
interleukin-4 (IL-4). Trypanosome-derived IL-4 is released
into the medium and is biologically active. The recombinant
protein down-regulates CD14 expression in human macro-
phages and inhibits NO production by stimulated bovine
macrophages. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
There is a general need for the production of recombinant
proteins in su⁄cient quantities to study their functions under
de¢ned conditions. This is particularly true of molecules such
as cytokines and growth factors, which are produced in trace
amounts in a whole organism and must otherwise be puri¢ed
from large amounts of tissue. Another reason why recombi-
nant molecules might be preferable is that factors derived
from cadavers, for example growth hormones from the pitui-
tary glands, carry the risk of being contaminated with patho-
genic agents such as viruses or prions.
A variety of bacterial and eukaryotic expression systems are
available for the expression of recombinant proteins. Prokary-
otic systems have the advantage of high yields and ease of
handling, but there are several major drawbacks. Proteins are
frequently insoluble and/or inactive. It has recently been dem-
onstrated that the way in which proteins are folded in bacteria
(post-translationally) is fundamentally di¡erent from the way
in which they are folded in eukaryotic cells (co-translationally)
and this may explain why many recombinant proteins assume
the wrong conformation when they are expressed in bacteria
[1]. In addition, bacteria are unable to glycosylate proteins,
which may a¡ect their biological activity, antigenicity and
stability in vivo. Expression systems using mammalian cells
are much more likely to produce correctly processed, func-
tional proteins, but the yields are much lower. Intermediate
between the bacterial and mammalian systems are the bacu-
lovirus/insect cell expression systems which give rise to parti-
ally glycosylated proteins.
An attenuated strain of Trypanosoma brucei o¡ers several
advantages as a eukaryotic expression system. The procyclic
form can easily be cultured in de¢ned media, grows rapidly
and can attain densities (s 3U107 ml31) that are about
10-fold greater than higher eukaryotic cells. Procyclic culture
forms are not infective for mammals and the subspecies
T. brucei brucei is not pathogenic for humans at any stage
of its life cycle. In contrast to bacteria, trypanosomes can
glycosylate [2], tyrosine phosphorylate [3] and add glycolipid
anchors to proteins [4,5]. Procyclic culture forms are covered
by a glycoprotein coat of several million procyclin molecules
[5,6]. The cells divide by binary ¢ssion, with a population
doubling time of V9^10 h in culture, and constitutively ex-
press high levels of procyclin in order to maintain the density
of the coat. We have used a locus containing two procyclin
genes as the basis for construction of the vector pGAPRONE
(Fig. 1). This is a bicistronic vector in which the reporter gene
and a selectable marker are £anked by the procyclin promoter
and the necessary sequences for e⁄cient processing of the
precursor RNA into monocistronic mRNAs [7]. When linear-
ised plasmids are introduced by electroporation, the vector
integrates by homologous recombination of the £anking re-
gions into a procyclin locus [8]. Six antibiotics that do not
show cross-resistance [9,10] are available for sequential rounds
of integration into de¢ned sites in the genome. This poten-
tially allows expression of multi-subunit complexes.
We have now used this system to produce stably trans-
formed trypanosomes that express recombinant bovine inter-
leukin-4 (rboIL-4) with a yield of approximately 3 million
molecules per cell. The protein is released into the culture
supernatant and is biologically active in assays performed
with human and bovine macrophages.
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 0 3 1 - 9
*Corresponding author. Fax: (41)-31-631 46 84.
E-mail address: isabel.roditi@izb.unibe.ch (I. Roditi).
1 Present address: Sir William Dunn School of Pathology, South
Parks Road, Oxford OX1 3RE, UK.
Abbreviations: FBS, foetal bovine serum; GARP, glutamic acid/ala-
nine-rich protein; PBMC, peripheral blood bovine mononuclear cells;
(r)boIL-4, (recombinant) bovine interleukin-4; (r)huIL-4, (recombi-
nant) human interleukin-4; UTR, untranslated region
FEBS 25423 5-11-01
FEBS 25423FEBS Letters 508 (2001) 90^94
2. Materials and methods
2.1. Trypanosomes
Procyclic culture forms of T. brucei strain 427 and all derivatives
were cultured at 27‡C in SDM-79 medium [11] supplemented with 5%
foetal bovine serum (FBS; Gibco BRL, Basel, Switzerland). Stable
transformants were cultured in medium containing 50 Wg ml31
G-418. Before harvesting culture supernatants for rboIL-4 bioassays,
the trypanosomes were washed twice in SDM-79 without G-418 and
cultured for several generations in SDM-79 supplemented with 5%
FBS. Supernatants were harvested from exponentially growing cul-
tures and centrifuged for 10 min at 1200Ug followed by sterile ¢ltra-
tion using a 0.25 Wm sterile ¢lter. The supernatants were aliquoted
and stored at 370‡C.
2.2. Construction of pG-boIL-4v164 and pG-mcsv164
The construction of the vector pGAPRONE-v164 (Fig. 1) is de-
scribed in detail elsewhere [7]. This plasmid contains a gene for the
trypanosome surface glycoprotein GARP (glutamic acid/alanine-rich
protein) and a neomycin resistance gene as a selectable marker. The
coding region of boIL-4 was ampli¢ed from a plasmid containing the
complete cDNA sequence [12] using the following primers: boIL-4A
(GGAAGCTTAATGGGTCTCAC) and boIL-4B (ACGGATCCTT-
CAACACTTGGA). Underlined sequences are synthetic HindIII and
BamHI restriction sites that were introduced to facilitate cloning. The
GARP gene was excised from pGAPRONE-v164 and replaced by the
ampli¢ed boIL-4 HindIII-BamHI fragment, resulting in the expression
vector pG-boIL-4v164 (Fig. 1). The pre¢x G indicates that the plas-
mid is derived from pGAPRONE and v164 refers to a truncated
procyclin 3P untranslated region (UTR) from which the ¢rst 164 nu-
cleotides have been deleted [7].
In the second generation construct pG-mcsv164 (Fig. 1), a small
multiple cloning site replaces the GARP gene. This was achieved by
digesting pGAPRONE-v164 with HindIII and BamHI and ligating it
with overlapping complementary oligonucleotides (AGCTTGAATT-
CTCGAGCTCCCGG and GATCCCGGGAGCTCGAGAATTCA)
that reconstituted the HindIII and BamHI sites and introduced a
further three unique sites (see Fig. 1).
2.3. Electroporation, G-418 selection and cloning
Procyclic culture forms of T. brucei 427 (5U107 cells) were electro-
porated with 5 Wg of pG-boIL-4v164 that was linearised by digestion
with KpnI and NotI. Electroporation was carried out with a Gene-
pulser (Bio-Rad) at 1.5 kV and 25 WF. Immediately after electropora-
tion, the cells were transferred into SDM-79 medium containing 5%
FBS and 50 Wg ml31 G-418 (Gibco BRL) and cultured at 27‡C.
G-418-resistant cells were cloned by limiting dilution in SDM-79 sup-
plemented with 20% FBS.
2.4. Northern and Western blot analysis
RNA was isolated from exponentially growing cells and prepared
for Northern blot analysis as described [13]. 10 Wg of total RNA was
denatured with glyoxal and dimethyl sulphoxide for 5 min at 50‡C,
separated on a 1.4% agarose gel and subsequently transferred to a
nylon membrane. The following hybridisation probes were used: a
PCR product corresponding to the 421-bp coding region of boIL-4
[12] and a genomic clone containing one copy each of K- and
L-tubulin [14]. Post-hybridisation washes were performed in 1USSC,
0.05% SDS at 65‡C.
Western blot analysis was performed as follows: 15 Wl culture
supernatant from exponentially growing trypanosomes was mixed
with protein sample bu¡er and boiled for 1 min. Alternatively, sam-
ples were denatured for 10 min at 100‡C in the presence of 0.5% SDS,
1% L-mercaptoethanol then incubated for 2 h at 37‡C in the presence
or absence of 500 U PNGase F (New England Biolabs). Samples were
separated by SDS^PAGE and transferred to nitrocellulose. The blot
was incubated with 5 Wg ml31 of monoclonal anti-boIL-4 (9D1; [15])
at room temperature for 1 h and subsequently with horseradish per-
oxidase-conjugated rat anti-mouse antibody (Dako Immunoglobulins,
Denmark) at a dilution of 1:1000. Antigen binding was visualised
with an enhanced chemoluminescence (ECL) detection kit (Amer-
sham, UK) according to the manufacturer’s instructions.
2.5. Cytokine bioassays: NO generation by bovine macrophages
Peripheral blood bovine mononuclear cells (PBMC) were isolated
from freshly drawn venous cattle blood by a modi¢ed Ficoll-hypaque
(Ficoll-triosyl) method [16]. 4U106 PBMC ml31 were sealed in cus-
tom-made bags from Te£on foil (type 100 A; Du-Pont de Nemours,
purchased through Angst and P¢ster, Zu«rich, Switzerland). The cells
were cultured in Iscove’s modi¢ed Dulbecco’s medium (Seromed, Mu-
nich, Germany) with the following additives: 10 mM HEPES, 1 mM
sodium pyruvate, 2 mM glutamine, 1% v/v non-essential amino acids
(Seromed), 1% v/v minimum essential medium (MEM) vitamin solu-
tion (Seromed), 100 IU ml31 penicillin, 100 Wg ml31 streptomycin, 10
Wg ml31 neomycin, and 20% heat-inactivated FBS low in endotoxin
(Life Technologies, Basel, Switzerland). Bags were incubated in a
humidi¢ed incubator at 37‡C, 5% CO2. After 1 week, the majority
of lymphocytes disappeared and monocytes had di¡erentiated into
macrophages. Cells were harvested and subcultured in cell culture
medium containing 5% FCS in £at-bottom 96-well plates in the pres-
ence of 200 Wg ml31 heat-inactivated (2 h at 60‡C) Listeria monocy-
togenes (strain NCTC 10,527) or Salmonella dublin and serial dilutions
of supernatants from trypanosome cultures. Twenty-four hours after
stimulation, supernatants were collected and nitrite, a stable metabo-
lite of NO was determined using the Griess reaction [17,18].
2.6. Down-regulation of CD14 in human macrophages
PBMC from human blood were isolated by isopycnic centrifugation
on Ficoll-hypaque as described [19]. Monocytes were enriched by an
adherence step using medium (see below) with 2% heat-inactivated
human AB serum, followed by three rinses with RPMI 1640. After
overnight culture in medium containing 10% heat-inactivated AB se-
rum, adherent cells were dislodged by vortexing. Cells were washed,
placed in Te£on bags and cultured at a density of 106 monocytes
ml31. The cells were cultured in RPMI 1640 medium containing 10
mM HEPES, 1 mM sodium pyruvate, 2 mM glutamine, 1% v/v non-
essential amino acids, 1% v/v MEM vitamin solution, 100 IU ml31
penicillin, 100 Wg ml31 streptomycin, 40 mg l31 folic acid and heat-
Fig. 1. Vectors for stable expression in T. brucei. The plasmids pG-
boIL4-v164 and pGmcs-v164 are derivatives of pGAPRONE-v164
in which the GARP gene has been replaced by the boIL4 coding re-
gion and a multiple cloning site, respectively. The vectors contain a
procyclin promoter (arrow), 5P UTR and £anking sequences neces-
sary for trans-splicing, a truncated procyclin 3P UTR and intergenic
regions responsible for the polyadenylation of the IL-4 mRNA. The
neomycin resistance gene (NEO) is preceded by procyclin 5P UTR
sequences and followed by a truncated 3P UTR and intergenic re-
gion. All modules can easily be exchanged due to unique restriction
sites: K = KpnI, H = HindIII, B = BamHI, X = XbaI, C = ClaI,
N = NheI and No = NotI. The neomcycin resistance gene can be re-
placed by cassettes conferring resistance to phleomycin, hygromycin,
nourseothricin and blasticidin [9,10]. The EcoRI, XhoI and SmaI
sites in pGmcs-v164 are unique. Integration occurs by homologous
recombination (in the regions shaded in grey) replacing the two pro-
cyclin genes EP1 and EP2. Coding regions are denoted by open
boxes and UTRs by black boxes.
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inactivated human AB serum. After cultivation for 7 ( þ 1) days the
cell population was highly enriched in macrophages (purity s 95%,
viability s 90%). Two days before harvesting, trypanosome superna-
tants were added to the Te£on bags. Cells were harvested and labelled
on ice with antibodies speci¢c for surface markers such as anti-CD11b
(Becton-Dickinson, San Jose, CA, USA), anti-CD14 (Becton-Dickin-
son and Dako, Glostrup, Denmark) and isotype control antibodies
(Coulter, Hialeah, FL, USA) at saturating concentrations. Some anti-
bodies were directly £uorescence-labelled; others were stained by an
indirect procedure, using phycoerythrin-labelled anti-mouse IgG
F(abP)2 fragments (Jackson Immunoresearch Laboratories, West
Grove, PA, USA). Stained cells were subjected to £ow cytometry,
using a FACScan analyser (Becton-Dickinson), and the PC-LYSYS
software. The level of surface marker expression was expressed as
mean £uorescence of cells within the macrophage gate, as determined
by light scatter properties of the cells.
3. Results and discussion
3.1. Production of stable transformants expressing boIL-4
The GARP open reading frame in the expression vector
pGAPRONE-v164 was replaced by boIL-4 to create the plas-
mid pG-boIL4-v164 (Fig. 1). Procyclic forms of T. brucei
were transfected by electroporation with linearised pG-boIL-
4v164, subjected to selection with G-418 and cloned by limit-
ing dilution. To verify that boIL-4 mRNA was expressed, a
Northern blot was hybridised simultaneously with probes for
boIL-4 and tubulin (Fig. 2A). RNA from trypanosomes sta-
bly transformed with the original pGAPRONE-v164 and
pGAPRONE-wt vectors was used as a negative control. IL-
4 transcripts were clearly detected in cells transformed with
pG-boIL-4v164 (lane G-boIL-4), but not in the negative con-
trols (lanes G-wt and G-v164).
Since the ampli¢ed IL-4 sequence encoded the entire pro-
tein including the bovine signal peptide, we analysed whether
rboIL-4 was released into the supernatant. Culture superna-
tants from G-boIL-4 trypanosomes and control trypanosomes
(G-wt) were subjected to Western blot analysis using a mono-
clonal anti-boIL-4 antibody [15]. As shown in Fig. 2B re-
combinant bovine IL-4 (Mr V17 kDa) was detected in super-
natants from G-boIL-4 transformants. The antibody reaction
was speci¢c as no proteins of this size were detectable in the
supernatant of control cells even after long exposure. Try-
panosome-derived boIL4 is larger than the predicted size of
the polypeptide backbone minus the signal peptide (12.6 kDa
[12]), suggesting that carbohydrates are linked to the protein.
Treatment with PNGase F caused a shift to Mr 14 kDa con-
¢rming that this is indeed the case (Fig. 2B). From these
results we conclude that T. brucei is able to express a glyco-
sylated form of rboIL-4 and that the bovine IL-4 signal pep-
tide is su⁄cient for direct release of the cytokine into the
culture supernatant.
3.2. Biological activity of recombinant bovine IL-4
To assess the biological activity of trypanosome-derived
rboIL-4, two di¡erent types of bioassay were performed. It
has been demonstrated that mouse and bovine macrophages
produce NO when exposed to Gram-negative bacteria, and
Fig. 2. A: IL-4 expression by T. brucei. 10 Wg of total RNA per
lane was subjected to Northern blot analysis using radiolabelled IL-
4 and tubulin probes. RNA was isolated from cells transformed
with pG-boIL-4v164 (G-boIL4). Two cell lines transformed with
pGAPRONE derivatives (G-wt and G-v164) serve as negative con-
trols. B: Trypanosome-derived boIL4 is secreted and glycosylated.
Left panel: Western blot with untreated supernatants. Proteins were
separated on a 15% SDS^polyacrylamide gel. G-boIL4: cells ex-
pressing boIL4. As a negative control, supernatants were harvested
from cells that had been stably transformed with the construct
pGAPRONE (G-wt). Right panel: mock-treated (3) ; incubated
with PNGase F (+).
Fig. 3. IL-4-mediated down-regulation of NO generation by bovine
monocyte-derived macrophages. Cells were exposed to S. dublin
(200 Wg ml31 and to the indicated concentrations of supernatants
from G-boIL-4 transformants (open bars) or with recombinant hu-
man IL-4 (dotted line). Nitrite, the stable metabolite of NO, was de-
termined by the Griess assay. The shaded area indicates the level of
nitrite formation in the presence of a control supernatant from
G-wt trypanosomes.
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that this can be inhibited by IL-4 [19,20]. Monocyte-derived
bovine macrophages were exposed to heat-inactivated S. dub-
lin in the presence of culture supernatants from G-boIL-4
trypanosomes. Twenty-four hours after stimulation, the mac-
rophages were harvested and the concentration of nitrite, a
stable metabolite of NO, was determined. A representative
dose^response curve is shown in Fig. 3. A 1:4050 dilution
of the G-boIL-4 supernatant already caused a signi¢cant re-
duction in NO production, and a 1:150 dilution reduced ni-
trite levels more than 10-fold. To ensure that this e¡ect was
not caused by other factors released by the trypanosomes, a
control supernatant from G-wt trypanosomes was also tested
in the assay. This supernatant did not cause any inhibition of
NO production by macrophages, con¢rming that the biolog-
ical activity was due to rboIL-4. To estimate the amount of
rboIL-4 in the culture supernatant, an assay was also per-
formed with de¢ned amounts of human recombinant IL-4
(rhuIL-4; Fig. 3, curve). This allowed us to estimate the
amount of rboIL-4 in the trypanosome culture supernatant
as being equivalent to 1^2 Wg ml31 huIL-4.
Another e¡ect of IL-4 is to down-regulate the surface
marker CD14 on human macrophages [21,22]. This was ex-
ploited in a second bioassay in which human macrophages
were exposed to di¡erent concentrations of rhuIL-4 and try-
panosome-derived rboIL-4. CD14 expression was monitored
by £ow cytometry using an anti-CD14 monoclonal antibody
(Fig. 4). Compared to untreated cells (left panel) human mac-
rophages exposed to 10 ng ml31 or 2 ng ml31 rhuIL-4 showed
a signi¢cant reduction in CD14 expression. Exposure of the
cells to various dilutions of G-boIL-4 supernatant reduced the
CD14 expression in a similar manner (Fig. 4, middle panel)
whereas the control supernatant from G-wt did not have any
e¡ect on CD14 expression (Fig. 4, right panel). The expression
of other surface molecules, for example CD18, was not modu-
lated by rhuIL-4 or rboIL-4 (data not shown). These results
indicate that trypanosome-derived rboIL-4 must bind the
huIL-4 receptor and activate the appropriate signal transduc-
tion pathway.
3.3. Yield of IL-4
Recombinant boIL-4 has been transiently expressed in three
heterologous eukaryotic expression systems, COS cells [23],
bovine herpesvirus [24] and vaccinia virus [25]. In terms of
activity, the yields obtained from stably transformed trypano-
somes are comparable to those obtained from the bovine her-
pesvirus system and are 10^100-fold higher than from COS
cells and vaccinia virus. The amounts of cytokine produced
(1^2 mg l31) are in the same range as for other cytokines, for
example human leukaemia inhibitory factor, in Chinese ham-
ster ovary cells and mouse erythroleukaemia cells [26,27]. In
both cases, the yield could be scaled up to approximately 20
mg l31 when the cells were cultured in roller bottles, but 3^9
months were required to obtain 10 mg crude protein. The
advantage of the trypanosome system is that once stable
transformants are obtained they can be cultured without anti-
biotic selection and their rapid growth allows the production
of milligram amounts of protein within days. In addition, they
may prove a useful alternative for the expression of proteins
that are toxic for mammalian cells.
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